Jiaying Wang Selected Research

Inflammation (Inflammations)

1/2022	Ipriflavone as a non-steroidal glucocorticoid receptor antagonist ameliorates diabetic cognitive impairment in mice.
11/2020	DW14006 as a direct AMPKα1 activator improves pathology of AD model mice by regulating microglial phagocytosis and neuroinflammation.
10/2020	Antispasmodic Drug Drofenine as an Inhibitor of Kv2.1 Channel Ameliorates Peripheral Neuropathy in Diabetic Mice.
1/2020	DW14006 as a Direct AMPKα Activator Ameliorates Diabetic Peripheral Neuropathy in Mice.
10/2019	Peptide-Based Biosensing of Redox-Active Protein-Heme Complexes Indicates Novel Mechanism for Tumor Survival under Oxidative Stress.
10/2019	Disocin prevents postmenopausal atherosclerosis in ovariectomized LDLR-/- mice through a PGC-1α/ERα pathway leading to promotion of autophagy and inhibition of oxidative stress, inflammation and apoptosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jiaying Wang Research Topics

Disease

12	Neoplasms (Cancer) 05/2022 - 05/2016
6	Inflammation (Inflammations) 01/2022 - 10/2019
5	Ovarian Neoplasms (Ovarian Cancer) 03/2021 - 01/2020
4	Infections 05/2022 - 01/2014
4	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 01/2018
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 08/2017
3	Peripheral Nervous System Diseases (PNS Diseases) 11/2020 - 01/2020
3	Mitochondrial Diseases (Mitochondrial Disease) 11/2020 - 01/2020
3	Breast Neoplasms (Breast Cancer) 10/2019 - 05/2016
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 05/2022 - 01/2022
2	Cognitive Dysfunction 01/2022 - 11/2017
2	Disease Progression 10/2021 - 05/2019
2	Neoplasm Metastasis (Metastasis) 03/2021 - 01/2020
2	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2020 - 01/2018
2	Type 2 Diabetes Mellitus (MODY) 02/2020 - 10/2018
2	Virus Diseases (Viral Diseases) 10/2016 - 01/2014
1	Myopia 06/2022
1	Asphyxia (Suffocation) 02/2022
1	Congenital Heart Defects (Congenital Heart Defect) 02/2022
1	Birth Weight (Birth Weights) 02/2022
1	Sepsis (Septicemia) 02/2022
1	Rupture 02/2022
1	Newborn Respiratory Distress Syndrome 02/2022
1	Pregnancy-Induced Hypertension (Hypertension, Pregnancy Induced) 02/2022
1	Osteoporosis 01/2022
1	Anemia 01/2021
1	Neuroinflammatory Diseases 01/2021
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Iron-Deficiency Anemia (Anemia, Iron Deficiency) 01/2021
1	Nervous System Diseases (Neurological Disorders) 11/2020
1	Hyperalgesia 11/2020
1	Diabetes Complications 10/2020
1	Ovarian Diseases (Ovarian Disease) 09/2020
1	Ovarian Epithelial Carcinoma 01/2020
1	Psychotic Disorders (Schizoaffective Disorder) 01/2020
1	Delirium 01/2020
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2020
1	Ascites 01/2020

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 11/2020 - 10/2012
5	Messenger RNA (mRNA)IBA 05/2022 - 10/2012
5	Long Noncoding RNAIBA 05/2022 - 01/2020
5	Pharmaceutical PreparationsIBA 01/2022 - 10/2019
4	Peptides (Polypeptides)IBA 05/2022 - 10/2019
4	NAD (NADH)IBA 01/2022 - 01/2020
3	Biological ProductsIBA 10/2021 - 02/2020
3	Caspase 3 (Caspase-3)IBA 11/2020 - 10/2019
2	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2022 - 01/2021
2	Amyloid (Amyloid Fibrils)IBA 11/2020 - 01/2018
1	ELAV-Like Protein 1IBA 05/2022
1	Circular RNAIBA 05/2022
1	Complement System Proteins (Complement)IBA 03/2022
1	quinone (benzoquinone)IBA 01/2022
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2022
1	Caspase 1 (ICE Protease)IBA 01/2022
1	Aspartate-tRNA LigaseIBA 01/2022
1	Nicotinamide PhosphoribosyltransferaseIBA 01/2022
1	ipriflavoneIBA 01/2022
1	6-methyladenineIBA 01/2022
1	Oxidoreductases (Dehydrogenase)IBA 01/2022
1	saikosaponin DIBA 10/2021
1	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 03/2021
1	F 382IBA 03/2021
1	Coloring Agents (Dyes)IBA 01/2021
1	Anti-Allergic Agents (Antiallergic Agents)IBA 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	Sirtuin 1IBA 01/2021
1	p38 Mitogen-Activated Protein KinasesIBA 01/2021
1	desloratadine (Aerius)FDA LinkGeneric 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	SP6616IBA 11/2020
1	Cytotoxins (Cytolysins)IBA 11/2020
1	Scavenger Receptors (Scavenger Receptor)IBA 11/2020
1	pyrimidineIBA 11/2020
1	Parasympatholytics (Antispasmodics)IBA 10/2020
1	cycloadiphenine (drofenine)IBA 10/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2020
1	AntigensIBA 09/2020
1	Tumor Biomarkers (Tumor Markers)IBA 09/2020
1	CarbohydratesIBA 09/2020
1	nitazoxanide (NTZ)FDA Link 04/2020
1	Protective AgentsIBA 02/2020
1	VincamineIBA 02/2020
1	BenzodiazepinesIBA 01/2020
1	Lorazepam (Ativan)FDA LinkGeneric 01/2020
1	Fibrinogen (Factor I)FDA Link 01/2020
1	Chlorpromazine (Thorazine)FDA Link 01/2020
1	N 30IBA 01/2020
1	Haloperidol (Haldol)FDA LinkGeneric 01/2020
1	AntibodiesIBA 01/2020
1	Collagen Type I (Type I Collagen)IBA 01/2020
1	Hemeproteins (Heme Protein)IBA 10/2019

Therapy/Procedure

6	Therapeutics 05/2022 - 10/2019
3	Length of Stay 05/2018 - 05/2016
1	Lenses 06/2022
1	Blood Transfusion (Blood Transfusions) 02/2022
1	Artificial Respiration (Mechanical Ventilation) 02/2022
1	Palliative Care (Palliative Therapy) 01/2020
1	Critical Care (Surgical Intensive Care) 01/2020
1	Long-Term Care 01/2020
1	Immunotherapy 01/2020